These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 38692506)

  • 1. Value added medicines: what value repurposed medicines might bring to society?
    Toumi M; Rémuzat C
    J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
    [No Abstract]   [Full Text] [Related]  

  • 2. A Conceptual Framework for Life-Cycle Health Technology Assessment.
    Kirwin E; Round J; Bond K; McCabe C
    Value Health; 2022 Jul; 25(7):1116-1123. PubMed ID: 35779939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries.
    Nicod E; Annemans L; Bucsics A; Lee A; Upadhyaya S; Facey K
    Health Policy; 2019 Feb; 123(2):140-151. PubMed ID: 28400128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How health technology assessment can help to address challenges in drug repurposing: a conceptual framework.
    Abu-Zahra T; Grimm SE; Scholte M; Raymakers AJN; Kesselheim AS; Joore M
    Drug Discov Today; 2024 Jun; 29(6):104008. PubMed ID: 38692506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme.
    Raftery J; Hanney S; Greenhalgh T; Glover M; Blatch-Jones A
    Health Technol Assess; 2016 Oct; 20(76):1-254. PubMed ID: 27767013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries.
    Visintin E; Tinelli M; Kanavos P
    Health Policy; 2019 Feb; 123(2):118-129. PubMed ID: 30227974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments.
    Ciani O; Wilcher B; van Giessen A; Taylor RS
    Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTA challenges for appraising rare disease interventions viewed through the lens of an institutional multidimensional value framework.
    Wagner M; Goetghebeur MM; Ganache I; Demers-Payette O; Auclair Y; Olivier C; Arbour S; de Guise M
    Expert Rev Pharmacoecon Outcomes Res; 2023 Feb; 23(2):143-152. PubMed ID: 36542763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments.
    Juárez-López D; Schcolnik-Cabrera A
    Arch Med Res; 2021 Apr; 52(3):243-251. PubMed ID: 33190955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.
    Farah L; Davaze-Schneider J; Martin T; Nguyen P; Borget I; Martelli N
    Artif Intell Med; 2023 Jun; 140():102547. PubMed ID: 37210155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory considerations and intellectual property rights of repurposed drugs.
    Afzaal H; Waseem T; Saeed A; Noori FA; Obaidullah ; Babar MM
    Prog Mol Biol Transl Sci; 2024; 205():357-375. PubMed ID: 38789186
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.